½ÃÀåº¸°í¼
»óÇ°ÄÚµå
1559502
## ¼¼°èÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀå## Enteral Feeding Formulas |

¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î ÇÑ±Û°ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅä¸¦ À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁÖ½Ã±â ¹Ù¶ø´Ï´Ù.

**Àå³» ¿µ¾çÁ¦ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 78¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù**

2023³â 63¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°è Àå³» ¿µ¾çÁ¦ ½ÃÀåÀº 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 3.2% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 78¾ï ´Þ·¯¿¡ ÀÌ¸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇÏ³ªÀÎ Ç¥ÁØ Æ÷¹Ä·¯´Â CAGR 2.2%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 39¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áúº´ Æ¯ÀÌÀû Æ÷¹Ä·¯ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.2%·Î ÃßÁ¤µË´Ï´Ù.

**¹Ì±¹ ½ÃÀåÀº 17¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.5%·Î ¼ºÀå Àü¸Á**

¹Ì±¹ÀÇ °æÀå ¿µ¾çÁ¦ ½ÃÀåÀº 2023³â 17¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 16¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 5.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀÏº»°ú Ä³³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 0.6%¿Í 3.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 1.3%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

**¼¼°è °æÀå ¿µ¾çÁ¦ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à**

**°æÀå ¿µ¾çÁ¦´Â Çï½ºÄÉ¾îÀÇ ¿µ¾çÁö¿ø¿¡ ¾î¶² Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ´Â°¡? **

°æÀå ¿µ¾çÁ¦´Â °æ±¸ ¼·Ãë°¡ ¾î·ÆÁö¸¸ °Ç° À¯Áö¿Í Áúº´ È¸º¹¿¡ ÇÊ¿äÇÑ ¿µ¾ç¼Ò¸¦ ÇÊ¿ä·Î ÇÏ´Â È¯ÀÚµé¿¡°Ô °úÇÐÀûÀ¸·Î °³¹ßµÈ ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á Çï½ºÄÉ¾î ºÐ¾ßÀÇ ¿µ¾ç °ø±Þ¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÀÌ Æ¯¼ö Æ÷¹Ä·¯´Â ¿µ¾ç Æ©ºê¸¦ ÅëÇØ ¼ÒÈ°ü¿¡ Á÷Á¢ Åõ¿©ÇÏµµ·Ï ¼³°èµÇ¾î È¯ÀÚ°¡ ´Ü¹éÁú, Åº¼öÈ¹°, Áö¹æ, ºñÅ¸¹Î, ¹Ì³×¶öÀÇ ±ÕÇü ÀâÈù ¼·Ãë¸¦ ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. °æÀå ¿µ¾çÁ¦´Â ÁßÈ¯ÀÚ½Ç(ICU)ÀÇ ÁßÁõ È¯ÀÚºÎÅÍ Å©·Ðº´, ¾Ï, »ïÅ´ Àå¾Ö°¡ ÀÖ´Â ½Å°æ°è ÁúÈ¯ µî ¸¸¼º ÁúÈ¯ È¯ÀÚ±îÁö ´Ù¾çÇÑ ÁúÈ¯°ú ¿µ¾ç ¿ä±¸ »çÇ×À» ÃæÁ·ÇÕ´Ï´Ù. °æÀå ¿µ¾çÁ¦´Â Á¤È®ÇÑ ¿µ¾ç °ø±ÞÀ» ÅëÇØ ¿µ¾ç ºÎÁ·À» ¿¹¹æÇÏ°í È¸º¹À» Áö¿øÇÏ¸ç Àü¹ÝÀûÀÎ °Ç° »óÅÂ¸¦ °³¼±ÇÏ´Â µî È¯ÀÚ Ä¡·á¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. °³º°ÈµÇ°í È¿°úÀûÀÎ ÀÇ·á¿ë ¿µ¾ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó, ÀÌ·¯ÇÑ Ã³¹æÀº Çö´ë ÀÇ·á¿¡ ÇÊ¼öÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖÀ¸¸ç, Ãë¾àÇÑ È¯ÀÚ Áý´Ü¿¡ »ý¸í À¯Áö¿¡ ÇÊ¿äÇÑ Áö¿øÀ» Á¦°øÇÕ´Ï´Ù.

**°æÀå ¿µ¾çÁ¦ÀÇ ±â´É¼ºÀ» ³ôÀÌ´Â Çõ½ÅÀÌ¶õ? **

°æÀå ¿µ¾çÁ¦ÀÇ Çõ½ÅÀº ¼ººÐ ¹èÇÕ, Ç¥Àû ¿µ¾ç ¹× Àü´Þ ½Ã½ºÅÛÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ±× ±â´ÉÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¹ßÀü Áß ÇÏ³ª´Â ´Ù¾çÇÑ È¯ÀÚ Áý´ÜÀÇ Æ¯Á¤ ¿ä±¸¸¦ ÃæÁ·ÇÏµµ·Ï Á¶Á¤µÈ Æ¯¼ö ¼ººÐÀÇ »ç¿ëÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ¿À¸Þ°¡3 Áö¹æ»ê, ½ÄÀÌ¼¶À¯, Áß¼âÁß¼ºÁö¹æ»ê(MCT) µîÀ» °ÈÇÑ Á¦Á¦´Â ¿°Áõ¼º ÁúÈ¯, Àå ±â´É ÀúÇÏ, Èí¼ö Àå¾Ö µî Æ¯Á¤ ´ë»çÀû ¿ä±¸°¡ ÀÖ´Â È¯ÀÚµéÀ» Áö¿øÇÏµµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Ç¥ÀûÈµÈ Á¦Á¦´Â ¿µ¾ç Èí¼ö¸¦ ÃÖÀûÈÇÏ°í °¢ È¯ÀÚÀÇ °íÀ¯ÇÑ ¿µ¾ç ¿ä±¸ »çÇ×À» ÃæÁ·½ÃÄÑ ÀÓ»ó °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Çõ½ÅÀº Æ¯Á¤ ÁúÈ¯ÀÇ Áõ»óÀ» °ü¸®ÇÏ°Å³ª ¿ÏÈÇÏ±â À§ÇØ Ã³¹æµÇ´Â ÁúÈ¯º° °æÀå ¿µ¾çÁ¦ °³¹ßÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ´ç´¢º´ È¯ÀÚ¸¦ À§ÇØ Æ¯º°È÷ °í¾ÈµÈ Á¦Á¦´Â Ç÷´ç ¼öÄ¡¸¦ °ü¸®ÇÏ±â À§ÇØ Åº¼öÈ¹° ¼öÄ¡¸¦ Á¶ÀýÇÕ´Ï´Ù. ¸¶Âù°¡Áö·Î ½ÅÀå ÁúÈ¯ È¯ÀÚ¸¦ À§ÇÑ Á¦Á¦´Â ´Ü¹éÁú, ³ªÆ®·ý, Ä®·ý ¼öÄ¡¸¦ ³·°Ô ¼³°èÇÏ¿© ½ÅÀåÀÇ ºÎ´ãÀ» ÁÙÀÏ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀ» ÅëÇØ ÀÇ·á ¼ºñ½º Á¦°ø¾÷Ã¼´Â º¸´Ù °³ÀÎÈµÈ ¿µ¾ç Áö¿øÀ» Á¦°øÇÔÀ¸·Î½á º¹ÀâÇÑ °Ç° ¿ä±¸°¡ ÀÖ´Â È¯ÀÚÀÇ »îÀÇ Áú°ú ÀÓ»ó °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àå³» ¿µ¾çÁ¦ Àü´Þ ½Ã½ºÅÛÀÇ ¹ßÀüÀº ÀÌ·¯ÇÑ Á¦Á¦ÀÇ ±â´É¼ºÀ» Å©°Ô Çâ»ó½ÃÅ°°í ÀÖ½À´Ï´Ù. ÃÖ½Å °æÀå¿µ¾ç ÆßÇÁ¿Í ½Ã½ºÅÛÀº »ç¿ë ÆíÀÇ¼º, Á¤È®¼º, È¯ÀÚÀÇ Æí¾ÈÇÔÀ» °í·ÁÇÏ¿© ¼³°èµÇ¾î ¿µ¾çÁ¦¸¦ ÀûÀýÇÑ ¼Óµµ¿Í ¾çÀ¸·Î Àü´ÞÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÈÞ´ë¿ë Àå¿µ¾ç ÆßÇÁ´Â È¯ÀÚ°¡ º´¿ø ¹Û¿¡¼µµ Àå¿µ¾ç °ø±ÞÀ» ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÏ¿© È¯ÀÚÀÇ ÀÌµ¿¼º°ú »îÀÇ ÁúÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ¶ÇÇÑ, ´õ ÀÛ°í Æí¾ÈÇÑ Æ©ºê¿Í ¸·Èû ¹æÁö ±â´ÉÀÇ °³¹ß µî Æ©ºê ±â¼úÀÇ ¹ßÀüÀ¸·Î Àå³» ¿µ¾ç °ø±Þ°ú °ü·ÃµÈ ÇÕº´ÁõÀÌ °¨¼ÒÇÏ¿© Àå±âÀûÀÎ ¿µ¾ç °ø±ÞÀ» À§ÇØ ´õ ¾ÈÀüÇÏ°í È¿°úÀûÀÎ ¼±ÅÃÀÌ µÇ¾ú½À´Ï´Ù.

ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î °æÀå ¿µ¾çÁ¦´Â ´õ¿í È¿°úÀûÀÌ°í °³ÀÎÈµÇ°í »ç¿ëÇÏ±â ½¬¿öÁ³À¸¸ç, ´Ù¾çÇÑ ÀÇ·á È¯°æ¿¡¼ »ç¿ëÀÌ È®´ëµÇ¾î ¿µ¾ç º¸Ãæ¿¡ ÀÇÁ¸ÇÏ´Â È¯ÀÚµéÀÇ »îÀ» °³¼±ÇÏ°í ÀÖ½À´Ï´Ù.

**°æÀå ¿µ¾çÁ¦´Â È¯ÀÚ Ä¡·á¿Í È¸º¹¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¨´Ï ±î? **

°æÀå ¿µ¾çÁ¦´Â Á¤»óÀûÀÎ ½Ä»ç¿Í ¼ÒÈ°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµµ °Ç° À¯Áö¿Í È¸º¹À» µ½°í Àü¹ÝÀûÀÎ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÇÊ¿äÇÑ ÇÊ¼ö ¿µ¾ç¼Ò¸¦ ¼·ÃëÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á È¯ÀÚÀÇ Ä¡·á¿Í È¸º¹¿¡ Å« ¿µÇâÀ» ¹ÌÄ¨´Ï´Ù. Àº È¯ÀÚÀÇ »ýÁ¸°ú È¸º¹¿¡ ÇÊ¼öÀûÀÔ´Ï´Ù. °æÀå ¿µ¾çÁ¦´Â ¿µ¾ç°áÇÌÀ» ¿¹¹æÇÏ°í, ±ÙÀ°·®À» À¯ÁöÇÏ¸ç, ¸é¿ª±â´ÉÀ» Áö¿øÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ÀÌ´Â ¼ö¼ú, ¿Ü»ó ¶Ç´Â ½É°¢ÇÑ Áúº´¿¡¼ È¸º¹ ÁßÀÎ È¯ÀÚ¿¡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °æÀå¿µ¾çÀº ÀûÀýÇÑ ¿µ¾ç ¼·Ãë¸¦ ÅëÇØ ÀÔ¿ø ±â°£À» ´ÜÃàÇÏ°í, °¨¿° À§ÇèÀ» ÁÙÀÌ¸ç, ½ÅÃ¼ÀÇ Ä¡À¯ ´É·ÂÀ» Çâ»ó½ÃÅ³ ¼ö ÀÖ±â ¶§¹®¿¡ ÁßÈ¯ÀÚ °ü¸®ÀÇ ÇÙ½ÉÀÔ´Ï´Ù.

¸¸¼º ÁúÈ¯À» ¾Î°í ÀÖ´Â È¯ÀÚµé¿¡°Ô Àå±âÀûÀÎ ¿µ¾ç Áö¿øÀ» Á¦°øÇÏ¸é »îÀÇ ÁúÀ» Å©°Ô Çâ»ó½ÃÅ³ ¼ö ÀÖ½À´Ï´Ù. ³úÁ¹ÁßÀÌ³ª ALS¿Í °°Àº ½Å°æ°è ÁúÈ¯À» ¾Î°í ÀÖ´Â È¯ÀÚµéÀº »ïÅ´ ±â´ÉÀ» ÀÒ¾î ¿µ¾ç ¿ä±¸¸¦ ÃæÁ·½ÃÅ°±â À§ÇØ °æÀå¿µ¾çÀÌ ÇÊ¿äÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î Å©·Ðº´ÀÌ³ª ´ÜÀå ÁõÈÄ±º°ú °°Àº À§Àå Àå¾Ö°¡ÀÖ´Â È¯ÀÚ´Â ¿µ¾ç Èí¼ö¿¡ Àå¾Ö°¡ÀÖ¾î ¿µ¾ç »óÅÂ¸¦ À¯ÁöÇÏ±â À§ÇØ Æ¯¼ö Ã³¹æ¿¡ ÀÇÁ¸ ÇÒ ¼ö ÀÖ½À´Ï´Ù. °æÀå ¿µ¾çÁ¦´Â ÀÏ°üµÇ°í ±ÕÇü ÀâÈù ¿µ¾ç¼Ò¸¦ °ø±ÞÇÔÀ¸·Î½á ÀÌ·¯ÇÑ È¯ÀÚµéÀÇ »óÅÂ¸¦ °ü¸®ÇÏ°í, ÇÕº´ÁõÀ» ¿¹¹æÇÏ¸ç, °Ç°»óÀÇ ¾î·Á¿ò¿¡µµ ºÒ±¸ÇÏ°í ´õ ³ªÀº »îÀÇ ÁúÀ» À¯ÁöÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¼Ò¾Æ°ú¿¡¼ °æÀå ¿µ¾çÁ¦´Â ¼±Ãµ¼º ÁúÈ¯, ÁßÁõ ¾Ë·¹¸£±â, ´ë»ç Àå¾Ö°¡ ÀÖ´Â ¾î¸°ÀÌÀÇ ¼ºÀå°ú ¹ß´ÞÀ» Áö¿øÇÏ´Â µ¥ ÇÊ¼öÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¼Ò¾Æ¿ë ¿ìÀ¯´Â ¼ºÀå±â ¾î¸°ÀÌÀÇ Æ¯º°ÇÑ ¿µ¾ç ¿ä±¸ »çÇ×À» ÃæÁ·ÇÏµµ·Ï Æ¯º°È÷ ¼³°èµÇ¾î ½ÅÃ¼ ¹× ÀÎÁö ±â´É ¹ß´ÞÀ» Áö¿øÇÏ´Â ÀûÀýÇÑ ¿µ¾ç¼Ò¸¦ ±ÕÇü ÀÖ°Ô ¼·ÃëÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ´Â Áúº´ÀÌ³ª ¹ß´Þ Áö¿¬À¸·Î ÀÎÇØ Á¤»óÀûÀÎ ½Ä´ÜÀ» ¼·ÃëÇÒ ¼ö ¾ø´Â ¿µÀ¯¾Æ¿¡°Ô Æ¯È÷ Áß¿äÇÕ´Ï´Ù.

¶ÇÇÑ, °æÀå ¿µ¾çÁ¦´Â ¸»±â ÁúÈ¯À» ¾Î°í ÀÖ´Â È¯ÀÚµé¿¡°Ô ¾ÈÁ¤À» ÁÖ°í ¿µ¾ç Áö¿øÀ» À¯ÁöÇÔÀ¸·Î½á ¿ÏÈ Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °æ¿ì, °æÀå¿µ¾çÀº Áõ»óÀ» °ü¸®ÇÏ°í Ã¼·ÂÀ» À¯ÁöÇÏ¸ç »îÀÇ ¸¶Áö¸· ´Ü°è¿¡¼ »îÀÇ ÁúÀ» Çâ»ó½ÃÅ°´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

Àå¿µ¾çÁ¦´Â ½Å·ÚÇÒ ¼ö ÀÖ°í Àü¹®ÀûÀÎ ¿µ¾ç Áö¿øÀ» Á¦°øÇÔÀ¸·Î½á ´Ù¾çÇÑ ÁúÈ¯À» °¡Áø È¯ÀÚ Ä¡·á¿¡ ÇÊ¼öÀûÀÌ¸ç È¸º¹, »îÀÇ Áú ¹× Àü¹ÝÀûÀÎ °Ç° °á°ú¿¡ Å« ¿µÇâÀ» ¹ÌÄ¨´Ï´Ù.

**Àå³» ¿µ¾çÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â Ãß¼¼´Â? **

ÀÎ±¸ °í·ÉÈ, ¸¸¼º ÁúÈ¯ÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ¿µ¾çÇÐÀÇ ¹ßÀü, ÀçÅÃ °£È£·ÎÀÇ ÀüÈ¯ µî ¿©·¯ °¡Áö Æ®·»µå°¡ °æÀå ¿µ¾çÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ°í ÀÖ½À´Ï´Ù. ¼¼°è ÀÎ±¸ÀÇ °í·ÉÈ·Î ÀÎÇØ ³úÁ¹Áß, Ä¡¸Å, ¾Ï°ú °°Àº »ïÅ´ Àå¾Ö ¹× ¿µ¾ç Èí¼ö Àå¾Ö¸¦ À¯¹ßÇÏ´Â ÁúÈ¯ÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÎ±¸ Ãß¼¼´Â °æ±¸ ¼·Ãë°¡ ¾î·Á¿î °í·É È¯ÀÚ¿¡°Ô ÇÊ¼öÀûÀÎ ¿µ¾çÀ» Á¦°øÇÒ ¼ö ÀÖ´Â °æÀå ¿µ¾çÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÌ¾îÁö°í ÀÖ½À´Ï´Ù. ´ç´¢º´, ½ÅºÎÀü, À§Àå Àå¾Ö¿Í °°Àº ¸¸¼º ÁúÈ¯ÀÇ À¯º´·ü Áõ°¡µµ ÀÌ·¯ÇÑ È¯ÀÚµéÀÇ ¿µ¾ç ¿ä±¸¸¦ ÃæÁ·½ÃÅ°±â À§ÇØ °í¾ÈµÈ Æ¯¼ö °æÀå ¿µ¾çÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.

ÀÇ·á ¿µ¾çÇÐÀÇ ¹ßÀüµµ ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. Áúº´ °ü¸®¿Í È¸º¹¿¡ ÀÖ¾î ¿µ¾çÀÇ ¿ªÇÒ¿¡ ´ëÇÑ ¿¬±¸°¡ ÁøÇàµÊ¿¡ µû¶ó Æ¯Á¤ ÁúÈ¯¿¡ ´ëÇÑ ¸ÂÃã½Ä Ã³¹æ °³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ´Ù¾çÇÑ °Ç° ¹®Á¦¸¦ °¡Áø È¯ÀÚµéÀÇ °íÀ¯ÇÑ ¿µ¾ç ¿ä±¸ »çÇ×À» ÃæÁ·ÇÏ´Â ´Ù¾çÇÑ ÁúÈ¯º° Ã³¹æÀÌ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ¿µ¾ç¿¡ ´ëÇÑ °ü½ÉÀº ¶ÇÇÑ Àå³» ¿µ¾ç Á¦Ç° Á¦Çü¿¡ ´ëÇÑ Çõ½ÅÀ» ÃËÁøÇÏ°í ÀÖÀ¸¸ç, Á¦Á¶¾÷Ã¼µéÀº ´õ ³ªÀº ¼ÒÈÀ², ¿µ¾ç Èí¼öÀ², È¯ÀÚ °á°ú °³¼±À» Á¦°øÇÏ´Â Á¦ÇüÀ» °³¹ßÇÏ°í ÀÖ½À´Ï´Ù.

ÀçÅÃ °£È£·ÎÀÇ ÀüÈ¯Àº °æÀå ¿µ¾çÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½ÃÅ°°í ÀÖ½À´Ï´Ù. ÀÇ·á ºñ¿ëÀÇ »ó½Â°ú ÀçÅÃÄ¡·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ ´õ ¸¹Àº È¯ÀÚµéÀÌ º´¿ø ¹Û¿¡¼ Ä¡·á¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë °æÀå¿µ¾ç½Ã½ºÅÛ°ú Àå±âº¹¿ëÀ» À§ÇÑ Á¦Á¦°¡ º¸ÆíÈµÇ°í ÀÖÀ¸¸ç, È¯ÀÚµéÀº º¸´Ù µ¶¸³ÀûÀÎ »îÀÇ ÁúÀ» À¯ÁöÇÏ¸é¼ ÇÊ¿äÇÑ ¿µ¾çÀ» °ø±Þ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Áö¼ÓÀûÀÎ ¿µ¾ç °ø±ÞÀÌ ÇÊ¿äÇÏÁö¸¸ Áý¿¡¼ »ýÈ°ÇÏ±â¸¦ ¿øÇÏ´Â ¸¸¼º ÁúÈ¯ È¯ÀÚµé¿¡°Ô Æ¯È÷ Áß¿äÇÕ´Ï´Ù.

¶ÇÇÑ, È¯ÀÚ Áß½ÉÀÇ Ä¡·á¿Í ÀÓ»ó °á°ú °³¼±ÀÇ ÇÊ¿ä¼º ¶§¹®¿¡ º´¿ø°ú ¿ä¾ç¿ø¿¡¼ºÎÅÍ ¿Ü·¡ È¯ÀÚ ¹× ÀçÅÃ ¿ä¾ç È¯°æ±îÁö ´Ù¾çÇÑ ÀÇ·á È¯°æ¿¡¼ °æÀå ¿µ¾çÁ¦ »ç¿ëÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°ø¾÷Ã¼°¡ ¿µ¾ç ¿ä¹ýÀ» ÃÖÀûÈÇÏ°í ¿µ¾ç½ÇÁ¶¿Í °ü·ÃµÈ ÇÕº´ÁõÀ» ÁÙÀÌ±â À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó °æÀå ¿µ¾çÁ¦ÀÇ »ç¿ëÀº °è¼Ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ·¯ÇÑ Ãß¼¼´Â °æÀå ¿µ¾çÁ¦°¡ Çö´ë ÀÇ·á¿¡¼ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. °æÀå ¿µ¾çÁ¦´Â ´Ù¾çÇÑ ÁúÈ¯À» °ü¸®ÇÏ°í, È¯ÀÚÀÇ È¸º¹À» µ½°í, Àü¹®ÀûÀÎ ¿µ¾ç Áö¿øÀÌ ÇÊ¿äÇÑ »ç¶÷µéÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃÅ°´Â Áß¿äÇÑ µµ±¸°¡ µÉ ¼ö ÀÖ±â ¶§¹®ÀÔ´Ï´Ù. ½ÃÀåÀÌ È®´ëµÊ¿¡ µû¶ó, Á¦Çü, Àü´Þ ¹× °³ÀÎ ¸ÂÃãÇü ¿µ¾ç °ø±Þ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº ÀÌ ÇÊ¼öÀûÀÎ Çï½ºÄÉ¾î ºÐ¾ß°¡ ´õ¿í ¼ºÀåÇÏ°í ¹ßÀüÇÒ ¼ö ÀÖ´Â ¿øµ¿·ÂÀÌ µÉ °ÍÀÔ´Ï´Ù.

- Albert David Ltd.
- ¹ÙÀÌ¿À´Ð½º °³¹ß ÁÖ½ÄÈ¸»ç
- BODCO DAIRY.
- Fresenius Kabi AG
- Global Health Products, Inc.
- Hormel Foods Corporation
- Mead Johnson & Company, LLC.
- Meiji Holdings Co.
- NutriDar

- ½ÃÀå °³¿ä
- ÁÖ¿ä ±â¾÷
- ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
- ¼¼°è ½ÃÀå Àü¸Á

- ¹Ì±¹
- Ä³³ª´Ù
- ÀÏº»
- Áß±¹
- À¯·´
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ¿µ±¹
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âÅ¸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- È£ÁÖ
- ÀÎµµ
- ÇÑ±¹
- ±âÅ¸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óÆ¾¾Æ¸Þ¸®Ä«
- ¾Æ¸£ÇîÆ¼³ª
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âÅ¸ ¶óÆ¾¾Æ¸Þ¸®Ä«
- Áßµ¿
- ÀÌ¶õ
- ÀÌ½º¶ó¿¤
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- ±âÅ¸ Áßµ¿
- ¾ÆÇÁ¸®Ä«

**Global Enteral Feeding Formulas Market to Reach US$7.8 Billion by 2030**

The global market for Enteral Feeding Formulas estimated at US$6.3 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2023-2030. Standard Formula, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Disease-Specific Formulas segment is estimated at 4.2% CAGR over the analysis period.

**The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 5.5% CAGR**

The Enteral Feeding Formulas market in the U.S. is estimated at US$1.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 5.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

**Global Enteral Feeding Formulas Market - Key Trends and Drivers Summarized**

**How Are Enteral Feeding Formulas Revolutionizing Nutritional Support in Healthcare?**

Enteral feeding formulas are revolutionizing nutritional support in healthcare by providing tailored, scientifically developed solutions for patients who are unable to consume food orally but still require essential nutrients to maintain health and recover from illness. These specialized formulas are designed to be administered directly into the gastrointestinal tract via a feeding tube, ensuring that patients receive a balanced intake of proteins, carbohydrates, fats, vitamins, and minerals. Enteral feeding formulas cater to a wide range of medical conditions and nutritional needs, from critical care patients in intensive care units (ICUs) to individuals with chronic conditions such as Crohn’s disease, cancer, or neurological disorders that impair swallowing. By delivering precise nutritional support, enteral feeding formulas play a crucial role in patient care, helping to prevent malnutrition, support recovery, and improve overall health outcomes. As the demand for personalized and effective medical nutrition continues to grow, these formulas are becoming an indispensable component of modern healthcare, offering life-sustaining support to vulnerable patient populations.

**What Innovations Are Enhancing the Functionality of Enteral Feeding Formulas?**

Innovations in enteral feeding formulas are enhancing their functionality through advancements in ingredient formulations, targeted nutrition, and delivery systems. One of the most significant developments is the use of specialized ingredients that are tailored to meet the specific needs of different patient populations. For example, formulas enriched with omega-3 fatty acids, fiber, or medium-chain triglycerides (MCTs) are designed to support patients with specific metabolic needs, such as those with inflammatory conditions, compromised gut function, or malabsorption issues. These targeted formulations help to optimize nutrient absorption and improve clinical outcomes by addressing the unique nutritional requirements of each patient.

Another key innovation is the development of disease-specific enteral feeding formulas that are formulated to manage or mitigate the symptoms of particular conditions. For instance, there are formulas specifically designed for patients with diabetes that provide controlled carbohydrate levels to manage blood glucose. Similarly, formulas for renal patients are designed with lower protein, sodium, and potassium levels to reduce the burden on the kidneys. Innovations like these allow healthcare providers to offer more personalized nutritional support, improving the quality of life and clinical outcomes for patients with complex health needs.

The evolution of delivery systems for enteral feeding is also significantly enhancing the functionality of these formulas. Modern enteral feeding pumps and systems are designed for ease of use, accuracy, and patient comfort, ensuring that the nutritional formulas are delivered at the correct rate and volume. Portable feeding pumps have made it possible for patients to receive enteral nutrition outside of the hospital setting, improving their mobility and quality of life. Additionally, advancements in tube technology, such as the development of smaller, more comfortable feeding tubes and anti-clogging features, have reduced complications associated with enteral feeding, making it a safer and more effective option for long-term nutritional support.

These innovations are making enteral feeding formulas more effective, personalized, and user-friendly, expanding their use in various healthcare settings and improving the lives of patients who rely on them for their nutritional needs.

**How Do Enteral Feeding Formulas Impact Patient Care and Recovery?**

Enteral feeding formulas have a profound impact on patient care and recovery by ensuring that individuals who cannot eat or digest food normally still receive the essential nutrients needed to maintain their health, support recovery, and improve overall outcomes. In critical care settings, such as ICUs, timely and appropriate nutritional support is vital for patient survival and recovery. Enteral feeding formulas help to prevent malnutrition, maintain muscle mass, and support immune function, all of which are crucial for patients recovering from surgery, trauma, or severe illness. Proper nutrition delivered through enteral feeding can shorten hospital stays, reduce the risk of infections, and enhance the body’s ability to heal, making it a cornerstone of critical care management.

For patients with chronic conditions, enteral feeding formulas provide long-term nutritional support that can significantly improve their quality of life. Patients with neurological disorders, such as stroke or ALS, may lose the ability to swallow and require enteral feeding to meet their nutritional needs. Similarly, individuals with gastrointestinal disorders, like Crohn’s disease or short bowel syndrome, may have impaired nutrient absorption and rely on specialized formulas to maintain their nutritional status. By providing a consistent and balanced supply of nutrients, enteral feeding formulas help these patients manage their conditions, prevent complications, and maintain a better quality of life despite their health challenges.

In pediatric care, enteral feeding formulas are essential for supporting the growth and development of children with congenital conditions, severe allergies, or metabolic disorders. Pediatric formulas are specially designed to meet the unique nutritional needs of growing children, ensuring they receive the right balance of nutrients to support their physical and cognitive development. This is particularly important for infants and young children who are unable to consume regular food due to medical conditions or developmental delays.

Additionally, enteral feeding formulas play a critical role in palliative care by providing comfort and maintaining nutritional support for patients with terminal illnesses. In these cases, enteral feeding helps to manage symptoms, maintain strength, and improve the quality of life in the final stages of life.

By providing reliable and specialized nutritional support, enteral feeding formulas are integral to patient care across a wide range of medical conditions, significantly impacting recovery, quality of life, and overall health outcomes.

**What Trends Are Driving Growth in the Enteral Feeding Formula Market?**

Several trends are driving growth in the enteral feeding formula market, including the aging population, increasing prevalence of chronic diseases, advancements in medical nutrition, and the shift towards home-based care. As the global population ages, the incidence of conditions that impair swallowing or nutrient absorption, such as stroke, dementia, and cancer, is increasing. This demographic trend is leading to greater demand for enteral feeding formulas that can provide essential nutrition for elderly patients who may not be able to consume food orally. The growing prevalence of chronic diseases, such as diabetes, renal failure, and gastrointestinal disorders, is also contributing to the demand for specialized enteral formulas designed to meet the nutritional needs of these patients.

Advancements in medical nutrition are another significant driver of market growth. As research into the role of nutrition in disease management and recovery advances, there is a growing emphasis on the development of formulas that are tailored to specific medical conditions. This has led to the creation of a wide range of disease-specific formulas that cater to the unique nutritional requirements of patients with different health challenges. The focus on personalized nutrition is also driving innovation in the formulation of enteral feeding products, with manufacturers developing formulas that offer better digestibility, enhanced nutrient absorption, and improved patient outcomes.

The shift towards home-based care is further boosting the demand for enteral feeding formulas. With the increasing cost of healthcare and the preference for at-home care, more patients are being managed outside of hospital settings. Portable enteral feeding systems and formulas designed for long-term use are becoming more common, allowing patients to receive the nutritional support they need while maintaining a greater degree of independence and quality of life. This trend is particularly important for patients with chronic conditions who require ongoing nutritional support but prefer to remain in their homes.

Additionally, the focus on patient-centered care and the need to improve clinical outcomes is driving the adoption of enteral feeding formulas in various healthcare settings, from hospitals and nursing homes to outpatient and home care environments. As healthcare providers seek to optimize nutrition therapy and reduce complications associated with malnutrition, the use of enteral feeding formulas is expected to continue growing.

These trends highlight the increasing importance of enteral feeding formulas in modern healthcare as they become a critical tool for managing a wide range of medical conditions, supporting patient recovery, and improving the quality of life for individuals who require specialized nutritional support. As the market expands, ongoing innovations in formulation, delivery, and personalized nutrition will likely drive further growth and development in this essential area of healthcare.

**Select Competitors (Total 46 Featured) - **

- Albert David Ltd.
- Bionix Development Corporation
- BODCO DAIRY.
- Fresenius Kabi AG
- Global Health Products, Inc.
- Hormel Foods Corporation
- Mead Johnson & Company, LLC.
- Meiji Holdings Co., Ltd.
- NutriDar

**1. MARKET OVERVIEW**- Influencer Market Insights
- Enteral Feeding Formulas - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update

**2. FOCUS ON SELECT PLAYERS****3. MARKET TRENDS & DRIVERS**- Rising Prevalence of Chronic Diseases and Malnutrition Driving Demand for Enteral Feeding Formulas
- Technological Innovations in Feeding Devices Complementing Use of Advanced Formulas
- Impact of Aging Populations Globally on Clinical Nutrition
- Growing Preference for Home Healthcare Solutions Fueling Formula Sales
- Development of Disease-Specific Formulas Enhancing Patient Recovery
- Market Trends Toward Organic and Non-GMO Feeding Solutions
- Expansion of Pediatric and Neonatal Nutrition Applications
- Emergence of Plant-Based and Allergen-Free Formula Options

**4. GLOBAL MARKET PERSPECTIVE**- TABLE 1: World Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Enteral Feeding Formulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 10: World Enteral Feeding Formulas Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Critical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Critical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Critical Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Standard Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Standard Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Standard Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Disease-Specific Formulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for Disease-Specific Formulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for Disease-Specific Formulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 30: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 33: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: World 16-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 36: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

**UNITED STATES**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 41: USA Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: USA 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: USA 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: USA 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 50: USA Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: USA Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: USA 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**CANADA**- TABLE 53: Canada Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: Canada 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: Canada 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 59: Canada Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: Canada Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: Canada 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 62: Canada Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: Canada Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: Canada 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**JAPAN**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 65: Japan Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: Japan 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 68: Japan Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: Japan Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: Japan 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 71: Japan Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: Japan Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Japan 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 74: Japan Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Japan Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Japan 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**CHINA**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 77: China Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: China Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: China 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 80: China Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: China Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: China 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 83: China Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: China Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: China 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 86: China Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: China Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: China 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**EUROPE**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 89: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 90: Europe Historic Review for Enteral Feeding Formulas by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Europe 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 92: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: Europe Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: Europe 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 95: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 96: Europe Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: Europe 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 98: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: Europe Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Europe 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 101: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Europe Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Europe 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**FRANCE**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 104: France Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: France Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: France 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 107: France Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 108: France Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: France 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 110: France Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: France Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: France 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 113: France Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 114: France Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 115: France 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**GERMANY**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 116: Germany Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 117: Germany Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 118: Germany 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 119: Germany Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 120: Germany Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 121: Germany 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 122: Germany Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 123: Germany Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 124: Germany 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 125: Germany Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 126: Germany Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 127: Germany 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**ITALY**- TABLE 128: Italy Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 129: Italy Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 130: Italy 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 131: Italy Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 132: Italy Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 133: Italy 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 134: Italy Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 135: Italy Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 136: Italy 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 137: Italy Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 138: Italy Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 139: Italy 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**UNITED KINGDOM**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 140: UK Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 141: UK Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 142: UK 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 143: UK Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 144: UK Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 145: UK 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 146: UK Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 147: UK Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 148: UK 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 149: UK Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 150: UK Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 151: UK 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**SPAIN**- TABLE 152: Spain Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 153: Spain Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 154: Spain 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 155: Spain Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 156: Spain Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 157: Spain 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 158: Spain Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 159: Spain Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 160: Spain 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 161: Spain Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 162: Spain Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 163: Spain 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**RUSSIA**- TABLE 164: Russia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 165: Russia Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 166: Russia 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 167: Russia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 168: Russia Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 169: Russia 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 170: Russia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 171: Russia Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 172: Russia 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 173: Russia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 174: Russia Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 175: Russia 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**REST OF EUROPE**- TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 177: Rest of Europe Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 178: Rest of Europe 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 180: Rest of Europe Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 181: Rest of Europe 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 183: Rest of Europe Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 184: Rest of Europe 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 186: Rest of Europe Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 187: Rest of Europe 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**ASIA-PACIFIC**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 189: Asia-Pacific Historic Review for Enteral Feeding Formulas by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 190: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 192: Asia-Pacific Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 193: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 195: Asia-Pacific Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 196: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 198: Asia-Pacific Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 199: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 201: Asia-Pacific Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 202: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**AUSTRALIA**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 203: Australia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 204: Australia Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 205: Australia 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 206: Australia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 207: Australia Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 208: Australia 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 209: Australia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 210: Australia Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 211: Australia 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 212: Australia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 213: Australia Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 214: Australia 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**INDIA**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 215: India Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 216: India Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 217: India 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 218: India Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 219: India Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 220: India 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 221: India Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 222: India Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 223: India 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 224: India Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 225: India Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 226: India 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**SOUTH KOREA**- TABLE 227: South Korea Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 228: South Korea Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 229: South Korea 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 230: South Korea Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 231: South Korea Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 232: South Korea 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 233: South Korea Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 234: South Korea Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 235: South Korea 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 236: South Korea Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 237: South Korea Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 238: South Korea 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**REST OF ASIA-PACIFIC**- TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 240: Rest of Asia-Pacific Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 243: Rest of Asia-Pacific Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 246: Rest of Asia-Pacific Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 249: Rest of Asia-Pacific Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**LATIN AMERICA**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 251: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 252: Latin America Historic Review for Enteral Feeding Formulas by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 253: Latin America 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 254: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 255: Latin America Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 256: Latin America 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 257: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 258: Latin America Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 259: Latin America 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 260: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 261: Latin America Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 262: Latin America 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 263: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 264: Latin America Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 265: Latin America 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**ARGENTINA**- TABLE 266: Argentina Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 267: Argentina Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 268: Argentina 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 269: Argentina Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 270: Argentina Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 271: Argentina 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 272: Argentina Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 273: Argentina Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 274: Argentina 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 275: Argentina Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 276: Argentina Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 277: Argentina 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**BRAZIL**- TABLE 278: Brazil Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 279: Brazil Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 280: Brazil 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 281: Brazil Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 282: Brazil Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 283: Brazil 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 284: Brazil Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 285: Brazil Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 286: Brazil 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 287: Brazil Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 288: Brazil Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 289: Brazil 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**MEXICO**- TABLE 290: Mexico Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 291: Mexico Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 292: Mexico 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 293: Mexico Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 294: Mexico Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 295: Mexico 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 296: Mexico Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 297: Mexico Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 298: Mexico 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 299: Mexico Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 300: Mexico Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 301: Mexico 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**REST OF LATIN AMERICA**- TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 303: Rest of Latin America Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 304: Rest of Latin America 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 306: Rest of Latin America Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 307: Rest of Latin America 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 309: Rest of Latin America Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 310: Rest of Latin America 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 312: Rest of Latin America Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 313: Rest of Latin America 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**MIDDLE EAST**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 314: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 315: Middle East Historic Review for Enteral Feeding Formulas by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 316: Middle East 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 317: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 318: Middle East Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 319: Middle East 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 320: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 321: Middle East Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 322: Middle East 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 323: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 324: Middle East Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 325: Middle East 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 326: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 327: Middle East Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 328: Middle East 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**IRAN**- TABLE 329: Iran Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 330: Iran Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 331: Iran 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 332: Iran Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 333: Iran Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 334: Iran 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 335: Iran Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 336: Iran Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 337: Iran 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 338: Iran Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 339: Iran Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 340: Iran 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**ISRAEL**- TABLE 341: Israel Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 342: Israel Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 343: Israel 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 344: Israel Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 345: Israel Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 346: Israel 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 347: Israel Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 348: Israel Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 349: Israel 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 350: Israel Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 351: Israel Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 352: Israel 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**SAUDI ARABIA**- TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 354: Saudi Arabia Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 355: Saudi Arabia 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 357: Saudi Arabia Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 358: Saudi Arabia 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 360: Saudi Arabia Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 361: Saudi Arabia 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 363: Saudi Arabia Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 364: Saudi Arabia 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**UNITED ARAB EMIRATES**- TABLE 365: UAE Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 366: UAE Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 367: UAE 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 368: UAE Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 369: UAE Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 370: UAE 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 371: UAE Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 372: UAE Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 373: UAE 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 374: UAE Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 375: UAE Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 376: UAE 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**REST OF MIDDLE EAST**- TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 378: Rest of Middle East Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 379: Rest of Middle East 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 381: Rest of Middle East Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 382: Rest of Middle East 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 384: Rest of Middle East Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 385: Rest of Middle East 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 387: Rest of Middle East Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 388: Rest of Middle East 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

**AFRICA**- Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 389: Africa Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 390: Africa Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 391: Africa 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2024 & 2030
- TABLE 392: Africa Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 393: Africa Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 394: Africa 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2024 & 2030
- TABLE 395: Africa Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 396: Africa Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 397: Africa 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2024 & 2030
- TABLE 398: Africa Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 399: Africa Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 400: Africa 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2024 & 2030

02-2025-2992

(ÁÖ¸» ¹× °øÈÞÀÏ Á¦¿Ü)

(ÁÖ¸» ¹× °øÈÞÀÏ Á¦¿Ü)

°Ë»ö

ºñ±³¸®½ºÆ®